Get the Stockscreener App
9.85
1.30%
-0.14
Rxsight Inc stock is traded at $9.85, with a volume of 32,379.
It is down -1.30% in the last 24 hours and down -21.93% over the past month.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.
See More
Previous Close:
$9.99
Open:
$10
24h Volume:
32,379
Relative Volume:
0.04
Market Cap:
$404.38M
Revenue:
$128.29M
Net Income/Loss:
$-30.69M
P/E Ratio:
-12.01
EPS:
-0.82
Net Cash Flow:
$-27.17M
1W Performance:
-5.38%
1M Performance:
-21.93%
6M Performance:
-20.68%
1Y Performance:
-72.30%
1-Day Range:
$9.7901
$10.00
1-Week Range:
$9.70
$10.85
52-Week Range:
$6.32
$35.60
Rxsight Inc Stock (RXST) Company Profile
Name
Rxsight Inc
Sector
Industry
Phone
949-521-7822
Address
100 COLUMBIA STREET, ALISO VIEJO
Compare RXST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
9.835 | 410.76M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
127.05 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.48 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
365.09 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.70 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.86 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-15-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-10-25 | Downgrade | Jefferies | Buy → Hold |
| Jul-09-25 | Downgrade | BTIG Research | Buy → Neutral |
| Jul-09-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-09-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-19-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-15-25 | Initiated | Piper Sandler | Neutral |
| Apr-09-25 | Downgrade | UBS | Buy → Neutral |
| Apr-04-25 | Downgrade | JP Morgan | Overweight → Underweight |
| Apr-03-25 | Downgrade | BofA Securities | Buy → Underperform |
| Dec-20-24 | Downgrade | Stifel | Buy → Hold |
| Dec-11-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-06-24 | Initiated | UBS | Buy |
| Oct-29-24 | Initiated | Jefferies | Buy |
| Aug-20-24 | Reiterated | Needham | Buy |
| Aug-06-24 | Reiterated | Needham | Buy |
| May-07-24 | Reiterated | BTIG Research | Buy |
| Dec-13-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-12-23 | Initiated | Stifel | Buy |
| Dec-04-23 | Initiated | Morgan Stanley | Overweight |
| Apr-13-23 | Initiated | Oppenheimer | Outperform |
| Dec-12-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-08-22 | Initiated | Needham | Buy |
View All
Rxsight Inc Stock (RXST) Latest News
Will RxSight Inc. stock outperform international peers2026 world cup usa national team group stage playmakers possession football tactical prediction tactical review - Улправда
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Investors to Inquire about Securities Investigation - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. ... - Bluefield Daily Telegraph
Looking At The Narrative For RxSight (RXST) After A Better Than Feared Quarter - Yahoo Finance
RxSight CFO Shelley Thunen to Step Down - Orange County Business Journal
Income Plays: Will RxSight Inc stock outperform value stocksEarnings Growth Summary & Low Risk High Win Rate Picks - moha.gov.vn
RxSight director sells $108,618 in common stock - MSN
Trading the Move, Not the Narrative: (RXST) Edition - Stock Traders Daily
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference - The Manila Times
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc.RXST - PR Newswire
RxSight, Inc. (NASDAQ:RXST) Receives Average Recommendation of "Reduce" from Brokerages - MarketBeat
RxSight, Inc. (RXST) Misses Q4 Earnings Estimates - MSN
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Shareholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Shareholders to Reach Out - ACCESS Newswire
Institutional Owners May Take Dramatic Actions as RxSight, Inc.'s (NASDAQ:RXST) Recent 13% Drop Adds to One-year Losses - 富途牛牛
Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), MDxHealth (MDXH) and RxSight (RXST) - The Globe and Mail
RxSight enters transition agreement with outgoing CFO Shelley Thunen By Investing.com - Investing.com Australia
RxSight, Inc. Announces Transition of Chief Financial Officer Shelley Thunen - VisionMonday.com
RxSight enters transition agreement with outgoing CFO Shelley Thunen - Investing.com
RxSight Announces CFO Transition and Leadership Continuity Plan - TipRanks
RxSight Announces CFO Transition - TradingView — Track All Markets
RxSight (RXST) sets CFO transition and consulting deal, keeps 2025 outlook - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
RxSight CFO exit raises concerns over pace of recovery, BTIG says - Investing.com Canada
RxSight (NASDAQ:RXST) Shares Gap DownShould You Sell? - MarketBeat
RxSight Shares Fall After Company Says CFO Shelley Thunen to Step Down - marketscreener.com
RxSight down on CFO transition (RXST:NASDAQ) - Seeking Alpha
RxSight Chief Financial Officer Shelley Thunen to Step Down - marketscreener.com
Rxsight, Inc. announces chief financial officer transition - marketscreener.com
RxSight announces planned transition of longtime CFO Thunen - TipRanks
RXST FinancialsIncome Statement - Quiver Quantitative
RxSight, Inc. Announces CFO Transition - TradingView — Track All Markets
RxSight, Inc. Announces Chief Financial Officer Transition - GlobeNewswire
Tunwal E Rebound Backed by Sentiment ShiftPrice Support Zones & Free Real-Time Trading Alerts Every Day - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Thrivent Financial for Lutherans Lowers Holdings in RxSight, Inc. $RXST - MarketBeat
RxSight Announces Executive Leadership Reorganization and New Appointments - TipRanks
RxSight, Inc. Announces Executive Appointments - TradingView — Track All Markets
RxSight, Inc. Appoints Eric Weinberg as Chief Business Development Officer and Scott Gaines as Chief Customer Officer, Effective December 18, 2025 - marketscreener.com
RxSight Earnings Notes - Trefis
Why RxSight Inc. stock is a value investor pickDip Buying & Safe Entry Trade Signal Reports - DonanımHaber
Will RxSight Inc. stock outperform value stocks2025 Sector Review & Expert Verified Stock Movement Alerts - DonanımHaber
Is RxSight Inc. stock trading at a premium valuationJuly 2025 Breakouts & Risk Managed Investment Strategies - Улправда
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
RxSight announces executive leadership reorganization and new appointments - MSN
Midday Stock Roundup: RXSight Falls After CFO Announcement - Orange County Business Journal
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Investors to Connect - ACCESS Newswire
Squarepoint Ops LLC Raises Stock Holdings in RxSight, Inc. $RXST - MarketBeat
How the Narrative Surrounding RxSight Is Shifting After a Strong but Debated Quarter - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Wells Fargo Reaffirms Their Hold Rating on RxSight (RXST) - The Globe and Mail
Rxsight Inc Stock (RXST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
0.98%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):